Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€137.00

€137.00

-0.720%
-1.0
-0.720%
-
 
04.07.25 / Tradegate WKN: A14VPJ / Name: Natera / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...
Your prediction

Financial data and news for Natera

sharewise wants to provide you with the best news and tools for Natera, so we directly link to the best financial data sources.

News

Natera Stock: Insider Sales Cast Shadow on Growth
Natera Stock: Insider Sales Cast Shadow on Growth

Natera's stock has rewarded investors with an impressive 60% gain over the past twelve months, but recent insider transactions have raised eyebrows despite strong operational performance. On April

Natera Stock: Executives Sell Shares Amid Strong Performance
Natera Stock: Executives Sell Shares Amid Strong Performance

Natera, a medical laboratory company listed on NASDAQ with a market capitalization of €19.08 billion, recently saw several of its executives selling shares. CEO Steven Leonard sold company shares

Natera Stock: Insider Sales Amid Strong Financial Growth
Natera Stock: Insider Sales Amid Strong Financial Growth

Executives at molecular diagnostics company Natera have recently sold shares worth over $1.2 million, even as the company demonstrates impressive market performance. Board Chairman Matthew

27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks: https://g.foolcdn.com/editorial/images/813425/boardroom-2.jpg
27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks

Stanley Druckenmiller is in an elite league of investors that includes the likes of Warren Buffett. He ran his hedge fund firm, Duquesne Capital Management, for 30 years, posting eye-popping average